148 related articles for article (PubMed ID: 17543504)
1. Characterisation of levofloxacin-resistant clinical isolates of Streptococcus pyogenes in Bilbao, Spain.
Alonso R; Mateo E; Ezpeleta G; Cisterna R
Int J Antimicrob Agents; 2007 Aug; 30(2):183-5. PubMed ID: 17543504
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of fluoroquinolone-resistant clinical isolates of Streptococcus pyogenes in Barcelona, Spain.
Rivera A; Rebollo M; Sánchez F; Navarro F; Miró E; Mirelis B; Coll P
Clin Microbiol Infect; 2005 Sep; 11(9):759-61. PubMed ID: 16104992
[TBL] [Abstract][Full Text] [Related]
3. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
Malhotra-Kumar S; Van Heirstraeten L; Lammens C; Chapelle S; Goossens H
J Antimicrob Chemother; 2009 May; 63(5):886-94. PubMed ID: 19279051
[TBL] [Abstract][Full Text] [Related]
4. High-level fluoroquinolone resistance in a clinical Streptoccoccus pyogenes isolate in Germany.
Reinert RR; Lütticken R; Al-Lahham A
Clin Microbiol Infect; 2004 Jul; 10(7):659-62. PubMed ID: 15214881
[TBL] [Abstract][Full Text] [Related]
5. Clonal spread of pediatric isolates of ciprofloxacin-resistant, emm type 6 Streptococcus pyogenes.
Alonso R; Mateo E; Galimand M; Garaizar J; Courvalin P; Cisterna R
J Clin Microbiol; 2005 May; 43(5):2492-3. PubMed ID: 15872292
[TBL] [Abstract][Full Text] [Related]
6. Intrinsic reduced susceptibility of serotype 6 Streptococcus pyogenes to fluoroquinolone antibiotics.
Orscheln RC; Johnson DR; Olson SM; Presti RM; Martin JM; Kaplan EL; Storch GA
J Infect Dis; 2005 Apr; 191(8):1272-9. PubMed ID: 15776373
[TBL] [Abstract][Full Text] [Related]
7. Fluoroquinolone resistance in Streptococcus pyogenes.
Richter SS; Diekema DJ; Heilmann KP; Almer LS; Shortridge VD; Zeitler R; Flamm RK; Doern GV
Clin Infect Dis; 2003 Feb; 36(3):380-3. PubMed ID: 12539083
[TBL] [Abstract][Full Text] [Related]
8. Clonal spread of emm type 28 isolates of Streptococcus pyogenes that are multiresistant to antibiotics.
Mihaila-Amrouche L; Bouvet A; Loubinoux J
J Clin Microbiol; 2004 Aug; 42(8):3844-6. PubMed ID: 15297545
[TBL] [Abstract][Full Text] [Related]
9. Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003.
Richter SS; Heilmann KP; Beekmann SE; Miller NJ; Miller AL; Rice CL; Doern CD; Reid SD; Doern GV
Clin Infect Dis; 2005 Sep; 41(5):599-608. PubMed ID: 16080080
[TBL] [Abstract][Full Text] [Related]
10. In vitro induction and selection of fluoroquinolone-resistant mutants of Streptococcus pyogenes strains with multiple emm types.
Billal DS; Fedorko DP; Yan SS; Hotomi M; Fujihara K; Nelson N; Yamanaka N
J Antimicrob Chemother; 2007 Jan; 59(1):28-34. PubMed ID: 17065188
[TBL] [Abstract][Full Text] [Related]
11. Decrease in macrolide resistance and clonal instability among Streptococcus pyogenes in Portugal.
Silva-Costa C; Pinto FR; Ramirez M; Melo-Cristino J;
Clin Microbiol Infect; 2008 Dec; 14(12):1152-9. PubMed ID: 19046174
[TBL] [Abstract][Full Text] [Related]
12. Primary peritonitis due to Streptococcus pyogenes with reduced susceptibility to fluoroquinolones.
Doloy A; Godin C; Decousser JW; Panel P; Greder-Belan A; Doucet-Populaire F
Diagn Microbiol Infect Dis; 2008 Dec; 62(4):447-9. PubMed ID: 18842379
[TBL] [Abstract][Full Text] [Related]
13. [Susceptibility of Streptococcus pyogenes to macrolides and quinolones in Guadalajara, Spain].
Rodríguez-Zurita ME; Solís del Baño S; Robres Guillén P; González Praetorius A; Gimeno Fernández C; Pérez Pomata MT; Bisquert Santiago J
Rev Esp Quimioter; 2003 Mar; 16(1):61-4. PubMed ID: 12750759
[TBL] [Abstract][Full Text] [Related]
14. Resistance to bacitracin in Streptococcus pyogenes from oropharyngeal colonization and noninvasive infections in Portugal was caused by two clones of distinct virulence genotypes.
Pires R; Rolo D; Mato R; Feio de Almeida J; Johansson C; Henriques-Normark B; Morais A; Brito-Avô A; Gonçalo-Marques J; Santos-Sanches I
FEMS Microbiol Lett; 2009 Jun; 296(2):235-40. PubMed ID: 19486163
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibility of Streptococcus pyogenes in Central, Eastern, and Baltic European Countries, 2005 to 2006: the cefditoren surveillance program.
Gracia M; Díaz C; Coronel P; Gimeno M; García-Rodas R; Rodríguez-Cerrato V; del Prado G; Huelves L; Ruiz V; Naves PF; Ponte MC; Granizo JJ; Soriano F
Diagn Microbiol Infect Dis; 2009 May; 64(1):52-6. PubMed ID: 19232860
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of emm types 1 and 12 from invasive Streptococcus pyogenes disease in Greece--results of enhanced surveillance.
Stathi A; Papaparaskevas J; Zachariadou L; Pangalis A; Legakis NJ; Tseleni-Kotsovili A; ; Tassios PT
Clin Microbiol Infect; 2008 Aug; 14(8):808-12. PubMed ID: 18727807
[TBL] [Abstract][Full Text] [Related]
17. Fluoroquinolone resistance in Streptococcus dysgalactiae subsp. equisimilis and evidence for a shared global gene pool with Streptococcus pyogenes.
Pinho MD; Melo-Cristino J; Ramirez M;
Antimicrob Agents Chemother; 2010 May; 54(5):1769-77. PubMed ID: 20145082
[TBL] [Abstract][Full Text] [Related]
18. Emerging fluoroquinolone-non-susceptible group A streptococci in two different paediatric populations.
Smeesters PR; Vergison A; Junior DC; Van Melderen L
Int J Antimicrob Agents; 2009 Jul; 34(1):44-9. PubMed ID: 19269141
[TBL] [Abstract][Full Text] [Related]
19. Decline in the prevalence of pandemic clones Spain23F-1 and Spain9V-3 among US fluoroquinolone-resistant Streptococcus pneumoniae TRUST Surveillance isolates since 2001.
Davies TA; Yee YC; Goldschmidt R; Sahm DF; Evangelista AT
Postgrad Med; 2008 Sep; 120(3 Suppl 1):39-45. PubMed ID: 18931470
[TBL] [Abstract][Full Text] [Related]
20. A family outbreak due to an emm-type 11 multiresistant strain of Streptococcus pyogenes.
Martinaud C; Doloy A; Graffin B; Gaillard T; Poyet R; Mallet S; Carsuzaa F; Brisou P; Bouvet A
Clin Microbiol Infect; 2010 Mar; 16(3):292-5. PubMed ID: 19519845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
